Patents by Inventor Matthias C Raggi

Matthias C Raggi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS
    Publication number: 20160136207
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34 stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34 stem cells used in the instant methods can be genetically, modified or not, depending on the disorder treated.
    Type: Application
    Filed: May 8, 2015
    Publication date: May 19, 2016
    Applicant: APCETH GMBH & CO. KG
    Inventors: Ralf Huss, Peter J. Nelson, Matthias C. Raggi, Manfred J. Stangl
  • CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS
    Publication number: 20150238526
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34 stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34 stem cells used in the instant methods can be genetically, modified or not, depending on the disorder treated.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Applicant: APCETH GMBH & CO. KG
    Inventors: Ralf Huss, Peter C. Nelson, Matthias C. Raggi, Manfred J. Stangl
  • CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS
    Publication number: 20150238541
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34 stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34 stem cells used in the instant methods can be genetically, modified or not, depending on the disorder treated.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Inventors: Ralf Huss, Peter C. Nelson, Matthias C. Raggi, Manfred J. Stangl, SR.
  • CD34 Stem Cell-Related Methods and Compositions
    Publication number: 20110268714
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34? stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34? stem cells used in the instant methods can be genetically modified or not, depending on the disorder treated.
    Type: Application
    Filed: July 8, 2011
    Publication date: November 3, 2011
    Inventors: Ralf HUSS, Matthias C. Raggi, Manfred J. Stangl, Peter C. Nelson
  • CD34 stem cell-related methods and compositions
    Patent number: 7998472
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34? stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34? stem cells used in the instant methods can be genetically modified or not, depending on the disorder treated.
    Type: Grant
    Filed: May 20, 2008
    Date of Patent: August 16, 2011
    Assignee: Apceth GmbH & Co. KG
    Inventors: Ralf Huss, Matthias C Raggi, Manfred J Stangl, Peter C Nelson
  • CD34 Stem cell-related methods and compositions
    Publication number: 20090041735
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34? stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34? stem cells used in the instant methods can be genetically modified or not, depending on the disorder treated.
    Type: Application
    Filed: May 20, 2008
    Publication date: February 12, 2009
    Applicant: Apceth GmbH & Co. KG
    Inventors: Ralf Huss, Matthias C. Raggi, Manfred J. Stangl, Peter C. Nelson